Sustainability/Impact Target ECG's position as a biotech consulting partner to emphasize end-to-end support for product development and commercialization, highlighting opportunities to offer product lifecycle optimization, regulatory strategy, and cross-functional program management to streamline time-to-market for medical devices and biotech products.

Small Team Advantage Leverage ECG's lean team size (2-10 employees) to position as an agile, highly customized advisory option for small-to-mid cap biotech startups and emerging tech firms seeking flexible engagement models, rapid onboarding, and focused senior-level expertise.

Longstanding Relationships Capitalize on ECG's track record of serving 50+ companies and retaining 85%+ client relationships to propose retainer-based advisory services, ongoing program management, and expanded scope with existing clients who may need additional commercialization, market access, or lifecycle support.

Tech & Cloud Enablement Propose technology-enabled consulting packages that utilize ECG's familiarity with cloud and web tech (Google Cloud, Nginx, OpenResty, etc.) to offer data integration, digital transformation, regulatory documentation automation, and secure collaboration platforms for multinational and entrepreneurial biotech programs.

Market & Competitive Intelligence Position ECG as a source of strategic competitive insights and program execution excellence to mid-to-large biopharma and medical device clients seeking differentiation, aiming at services around portfolio strategy, vendor ecosystem optimization, and cross-functional implementation parity across global teams.